The Street’s Key Stock Analysts Research Reports
$AMD, $ADT, $ALRM, $BKNG, $BP, $BHF, $CPB
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Monday, as follows:
Advanced Micro Devices Inc. (NASDAQ:AMD) analysts raised to Neutral from Sell and the price target was raised to 21 from 13.25 at Goldman Sachs. The 52-wk trading range for AMD is 9.04 – 20.18.
ADT Inc. (NYSE:ADT) was started as Outperform and assigned a 12.50 price target at Credit Suisse. The shares were up almost 3% at 8.70 Friday. The 52-wk trading range is 6.93 to 13.02, and the consensus target price is at 14.00.
Alarm.com Holdings Inc. (NASDAQ:ALRM) analysts started with an Outperform rating and assigned a 57 price target at Credit Suisse.
Booking Holdings Inc. (NASDAQ:BKNG): Analysts at Jefferies downgraded BKNG it to Hold from Buy with $2,060. Citigroup also lowered the stock, to Neutral from Buy with a 2,150 price target.
BP PLC (NYSE:BP) was added to the prized Conviction Buy list at Goldman Sachs, which noted that the Crude Oil giant is close to a sweet spot on free cash flow and with higher returns ahead, with 1 of the strongest pipelines of new Oil & Gas projects in the industry.
BrightHouse Financial Inc. (NYSE:BHF) analysts downgraded to Underweight from Equal Weight with a 42 price target at Barclays.
Campbell Soup Co. (NYSE:CPB) was downgraded to Underweight from Neutral at JPMorgan, with the firm noting that it sees a sale as not the most likely scenario, and if a sale does take place, the firm feels that the premium might not be great. Campbell Soup shares were down 2.3% at 41.32 Friday in New York.
Have a terrific week
Latest posts by Paul Ebeling (see all)
- The Street’s Key Stock Analysts Research Report - December 12, 2019
- Savvy Investors Seeing Gold at $2,500 oz Plus - December 11, 2019
- CBD Oil is Not a Dietary Supplement, Fed Cracks Down - December 11, 2019